stock price for ionis
NEW YORK (TheStreet) -- Shares of Ionis Pharmaceuticals (IONS) are plummeting by 31.96% to $23.99 on heavy trading volume Thursday morning, after the company's partner GlaxoSmithKline (GSK) decided against initiating a phase-three study for Ionis-TTR, which the companies have been co-developing.